What Are The Recommended 1064Nm Nd:yag Settings For Facial Telangiectasia? Safe Pulse Parameters & Technique

For facial telangiectasia, a commonly supported starting protocol is a 5 mm spot, 75–90 J/cm² fluence, and two pulses of approximately 5–13.5 ms separated by 20 ms, with continuous external cooling. Settings must still be adjusted to vessel caliber, depth, skin phototype, device design, and the observed tissue response by a trained medical laser practitioner.

The goal is controlled intravascular heating—not maximal energy delivery. Use a double-pulse sequence and cooling to allow the vessel to heat while limiting epidermal and dermal thermal accumulation.

Recommended Facial Treatment Parameters

Fluence and spot size

For facial telangiectasias, the primary evidence supports:

Fluence: approximately 75–90 J/cm²
Spot size: 5 mm
Wavelength: 1064 nm
Pulse format: double pulse

Some systems and clinical protocols use broader ranges, such as 75–100 J/cm², but higher fluences should not be adopted automatically. The correct value depends on vessel diameter, depth, skin pigmentation, cooling performance, and the specific laser handpiece.

Pulse duration and inter-pulse delay

Use two pulses with individual pulse durations of approximately 5–13.5 ms and an inter-pulse delay of 20 ms.

The delay permits partial thermal relaxation between pulses. This helps concentrate treatment in the vessel while reducing uncontrolled heat accumulation in the surrounding skin.

Cooling

Apply continuous external cooling during treatment. Contact cooling or another validated epidermal-cooling method helps protect the epidermis and improves patient comfort, particularly when using the relatively high fluences required by a 1064 nm Nd:YAG system.

Cooling should not be treated as a substitute for appropriate fluence selection or careful pulse delivery.

Why the 1064 nm Nd:YAG Approach Works

Deep vascular penetration

The 1064 nm wavelength penetrates relatively deeply into the dermis and is therefore useful for larger, deeper, or bluish facial vessels, including vessels around the nasal alae.

Its lower absorption by epidermal melanin than shorter wavelengths can also be advantageous in more pigmented skin. However, lower melanin absorption does not eliminate the risk of burns or post-inflammatory pigmentary change.

The role of high fluence

Hemoglobin absorbs 1064 nm light less strongly than it absorbs some shorter vascular wavelengths. The system therefore commonly relies on higher fluence and adequate pulse duration to produce sufficient heating of the vessel wall.

This does not mean that higher energy is always better. Excessive fluence can produce epidermal injury, scarring, or unwanted pigmentary changes.

Pulse Delivery Technique

Use a controlled double-pulse sequence

Deliver the two pulses as a defined sequence with the recommended inter-pulse delay rather than rapidly stacking pulses without a delay.

The intended effect is controlled vascular heating leading to intravascular coagulation, vessel collapse, or gradual clearance over the following weeks.

Follow the vessel path

Treat along the visible vessel in a controlled linear fashion, generally progressing from larger visible vessels toward smaller branches when clinically appropriate.

Avoid uncontrolled passes and maintain consistent handpiece contact, aiming, and pulse spacing.

Avoid spot overlap

Do not overlap treatment spots. Overlapping pulses can create local heat accumulation and increase the risk of epidermal damage, blistering, scarring, or textural change.

A device-specific spacing policy should be followed; some protocols recommend keeping adjacent spots separated rather than treating the same area repeatedly.

Do not stack pulses

Pulse stacking should be avoided with long-pulsed 1064 nm Nd:YAG treatment. Delivering additional pulses before adequate thermal relaxation can cause residual heat to accumulate in the dermis and epidermis.

This is distinct from the controlled two-pulse sequence with a specified 20 ms delay.

Clinical Endpoints and Monitoring

Desired tissue response

The practitioner should assess for evidence of effective vascular heating, such as:

Intravascular coagulation
Vessel collapse
Appropriate vessel darkening or disappearance
In some protocols, a limited linear hematoma may be observed

The endpoint must be interpreted in the context of the device and treatment area.

Warning signs of excessive energy

Immediate, marked, or diffuse skin bleaching can indicate excessive fluence or excessive thermal injury risk. Blistering, charred skin, pronounced epidermal whitening, or uncontrolled purpura are not desirable endpoints and require immediate reassessment.

Vessel rupture and excessive purpura should generally be avoided when the treatment objective is nonpurpuric telangiectasia clearance.

Follow-up timing

Final clearance should not be judged immediately. Reassessment is commonly performed after approximately 50–80 days, or several months, because vascular remodeling and clearance continue after treatment.

Understanding the Trade-offs

Higher fluence versus safety

Higher fluence may improve heating of deeper or larger vessels, but it also narrows the safety margin. Facial skin is generally less tolerant of aggressive settings than thicker tissue or lower-extremity vascular targets.

Protocols used for leg veins should not be transferred directly to the face.

Shorter versus longer pulses

Shorter pulses can be useful for smaller vessels when the device and tissue response support them. Longer pulses may be preferable for larger or deeper vessels or when a more conservative thermal delivery is needed.

Pulse duration should be selected according to vessel caliber and depth rather than used as an isolated preset.

Darker or tanned skin

Although 1064 nm has relatively low epidermal melanin absorption, darker or recently tanned skin still requires additional caution. Conservative starting parameters, effective cooling, test spots, and delayed assessment can reduce the risk of burns and dyschromia.

Conflicting parameter ranges

Published and device-specific protocols may list substantially wider ranges, including smaller spots, longer pulse durations, or higher fluences. These settings are not interchangeable with the focused facial protocol described above and should only be considered when supported by the specific device, indication, and clinician’s experience.

How to Apply This to Your Project

Use the following framework rather than treating the settings as a universal preset:

If your primary focus is standard facial telangiectasia: Begin within the evidence-supported range of 75–90 J/cm² with a 5 mm spot, using two 5–13.5 ms pulses separated by 20 ms, plus continuous external cooling.
If your primary focus is darker or tanned skin: Use a conservative, device-validated setting, perform a test area when appropriate, and prioritize cooling and delayed evaluation over aggressive clearance.
If your primary focus is larger or deeper vessels: Confirm whether the device protocol supports a longer pulse duration or modified fluence, and adjust according to vessel caliber rather than importing leg-vein settings.
If your primary focus is minimizing complications: Avoid spot overlap and unscheduled pulse stacking, monitor the immediate endpoint closely, and stop if signs of excessive epidermal heating appear.

A safe protocol balances vessel clearance against thermal injury risk, using controlled double-pulse delivery, adequate cooling, and individualized parameter adjustment.

Summary Table:

Parameter	Recommended Range	Notes
Wavelength	1064 nm	Deep penetration, lower melanin absorption
Spot size	5 mm	Common for facial telangiectasia
Fluence	75–90 J/cm²	Adjust based on vessel size, depth, skin type
Pulse format	Double pulse	Two pulses, 5–13.5 ms each
Inter-pulse delay	20 ms	Allows partial thermal relaxation
Cooling	Continuous external	Protects epidermis, improves comfort
Endpoint	Intravascular coagulation, vessel collapse	Avoid excessive purpura or whitening
Follow-up	50–80 days	Assess final clearance clinically

Achieve safe and effective facial vascular treatments with BELIS' advanced 1064nm Nd:YAG systems, designed for clinics and premium salons. Our professional-grade laser platforms offer precise pulse control and integrated cooling to optimize outcomes for telangiectasia, while our comprehensive portfolio includes diode, Alexandrite, CO2, and more. Partner with us to access cutting-edge technology, OEM/ODM support, and certified reliability. Contact our experts today to elevate your aesthetic practice and deliver superior patient satisfaction.